Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dare Bioscience, Inc.DARE · Entity 7799 | Director | June 30, 2026 | July 02, 2026 |
| ONE STOP SYSTEMS, INC.OSS · Entity 2767 | Director | May 20, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dare Bioscience, Inc.
Report date June 30, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 30,847 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 30,805 · Balance 30,847 F1: Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027.
ONE STOP SYSTEMS, INC.
Report date May 20, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,914 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 11,984 · Balance 86,914 F1: Represents 11,984 restricted stock units granted to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions. F2: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 74,930 shares of common stock. |
| Common StockSEC Table I · non-derivative | Direct | 78,914 |
Reported balance
After 2026-05-26 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-05-26 · Sale · Disposed 8,000 · Balance 78,914 F3: The Reporting Person sold 8,000 shares of common stock upon conversion of an aggregate 21,000 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of sale. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on May 23, 2025. F4: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 66,930 shares of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 11,984 restricted stock units granted to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions.
F2: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 74,930 shares of common stock.
F3: The Reporting Person sold 8,000 shares of common stock upon conversion of an aggregate 21,000 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of sale. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on May 23, 2025.
F4: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 66,930 shares of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 2, 2026 20:21 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantCommon stock | 30,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001401914-26-000035 · wk-form4_1783023684.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,847 F1 · shares: Represents shares underlying restricted stock units ("RSU") granted to the reporting person in lieu of cash compensation for service on the issuer's board of directors and its committees. Each RSU represents a contingent right to receive one share when vested. The RSUs vests on January 4, 2027. Read SEC document |
| June 11, 2026 Filed Jun 11, 2026 20:52 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001536574-26-000002 · wk-form4_1781211127.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common stock · 10,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| May 26, 2026 Filed May 26, 2026 21:44 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | SaleCommon Stock | 8,000 | $17.52 | $140,160.00 |
DisclosureSEC source: 0001193125-26-239727 · ownership.xml · nonDerivative · entry 2 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,914 F3 · shares: The Reporting Person sold 8,000 shares of common stock upon conversion of an aggregate 21,000 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of sale. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on May 23, 2025. F4 · balance_after: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 66,930 shares of common stock. Read SEC document |
| May 20, 2026 Filed May 26, 2026 21:44 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantCommon Stock | 11,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-239727 · ownership.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,914 F1 · shares: Represents 11,984 restricted stock units granted to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions. F2 · balance_after: Includes 11,984 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 74,930 shares of common stock. Read SEC document |
| July 09, 2025 Filed Jul 10, 2025 20:05 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001401914-25-000038 · wk-form4_1752177931.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common stock · 4,500 shares Expires 2035-07-09 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| May 21, 2025 Filed May 23, 2025 23:10 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantCommon Stock | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077237 · ownership.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,930 F1 · shares: Represents 21,000 restricted stock units granted to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions. F2 · balance_after: Includes 21,000 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions and 53,930 shares of common stock. Read SEC document |
| July 01, 2024 Filed Jul 4, 2024 00:55 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantCommon Stock | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-081744 · ownership.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,930 F1 · shares: Represents 21,000 restricted stock units granted to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions. F2 · balance_after: Includes 21,000 unvested restricted stock units held by the Reporting Person, all of which remain subject to certain vesting conditions. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:15 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001493152-24-023177 · ownership.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| August 15, 2023 Filed Aug 15, 2023 22:58 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | PurchaseCommon Stock | 2,500 | $1.77 | $4,425.00 |
DisclosureSEC source: 0001209191-23-045920 · doc4.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,930 Read SEC document |
| June 21, 2023 Filed Jun 22, 2023 01:38 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001401914-23-000026 · wk-form4_1687397884.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2033-06-21 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:49 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001401914-22-000069 · wf-form4_165610375926172.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common stock · 38,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| March 17, 2022 Filed Mar 22, 2022 01:19 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantCommon Stock | 13,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020446 · doc4.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,430 F1 · shares: Represents 13,100 restricted stock units awarded to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, which restricted stock units are subject to vesting conditions. F2 · balance_after: Includes 13,100 unvested restricted stock units held by the Reporting Person, which remain subject to certain vesting conditions. Read SEC document |
| June 24, 2021 Filed Jun 24, 2021 20:56 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001401914-21-000101 · wf-form4_162456818462982.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:07 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantCommon Stock | 8,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035056 · doc4.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,330 F1 · shares: Represents 8,666 restricted stock units awarded to the Reporting Person under the Issuer's 2017 Equity Incentive Plan, as amended (the "Plan"), in connection with the Reporting Person's service as a director of the Issuer, certain of which restricted stock units are subject to vesting conditions. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 11:00 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | Exercise / conversionRestricted Stock Units · Derivative | 6,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011125 · doc4.xml · derivative · entry 2 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,164 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 3, 2020, the reporting person was granted 6,164 restricted stock units that vested on February 11, 2021. F2 · derivative.expiration_date: On August 3, 2020, the reporting person was granted 6,164 restricted stock units that vested on February 11, 2021. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 11:00 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | Exercise / conversionCommon Stock | 6,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011125 · doc4.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 00:36 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | PurchaseCommon Stock | 2,500 | $2.28 | $5,700.00 |
DisclosureSEC source: 0001209191-20-047372 · doc4.xml · nonDerivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By The Matz Trust Disclosed balance after: 2,500 Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 01:02 UTC | ONE STOP SYSTEMS, INC. OSS · Entity 2767 | GrantRestricted Stock Unit · Derivative | 6,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045401 · doc4.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,164 Underlying: Common Stock · 6,164 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. The closing price of the issuer on August 3, 2020 was $2.48. F1 · date: Each Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. The closing price of the issuer on August 3, 2020 was $2.48. F2 · derivative.exercise_date: On August 3, 2020, the reporting person was granted 6,164 restricted stock units vesting on February 10, 2021. F2 · derivative.expiration_date: On August 3, 2020, the reporting person was granted 6,164 restricted stock units vesting on February 10, 2021. Read SEC document |
| June 25, 2020 Filed Jun 27, 2020 00:57 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001401914-20-000098 · wf-form4_159321940289407.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2030-06-25 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 11:04 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 22,500 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001536574-19-000001 · wf-form4_156051028016144.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 21:45 UTC | Dare Bioscience, Inc. DARE · Entity 7799 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001209191-18-051267 · doc4.xml · derivative · entry 1 Matz Gregory W · CIK 0001536574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-09-13 F1 · derivative.exercise_date: This option vests as to 1/3rd of the shares subject to this option on each of the first three anniversaries of the transaction date, subject to the reporting person's continued service to the issuer, and will become exercisable in full upon a change of control of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.